3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Alcohol Drinking
4
Substance-Related Disorders
1
Social Isolation
1
Smoking Cessation
1
Risk-Taking
1
Pancreatic Cyst
1
Head and Neck Neoplasms
1
Driving Under the Influence
1
Depression
1
Carney Complex
1
Binge-Eating Disorder
1
Binge Drinking
1
Interventions
Bevacizumab
39
atezolizumab
26
durvalumab
24
Nivolumab
21
lenvatinib
20
tremelimumab
16
Specimen Handling
16
Magnetic Resonance Spectroscopy
13
sintilimab
11
pembrolizumab
11
Ipilimumab
10
tislelizumab
7
X-Rays
7
Sorafenib
7
Immunoglobulin G
7
regorafenib
6
Disulfides
6
Cyclophosphamide
6
cabozantinib
5
Radiotherapy
5
Radiosurgery
5
Blood Specimen Collection
5
Radiation
4
Oxaliplatin
4
Immunotherapy
4
Fluorouracil
4
Ethiodized Oil
4
Biopsy
4
fludarabine
3
donafenib
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Hepatocellular
×
Ethanol
×
90 days
×
Clear all
No trials found.